Avanos Medical, Inc., a well-known medical technology company listed on the NYSE under the ticker AVNS, has announced it has bought Nexus Medical, LLC, a privately owned medical device company based in Lenexa, Kansas. Nexus is famous for creating the TKO anti-reflux needleless connector, a special device that helps make nutrition and medication delivery safer and more reliable in critical care areas like Neonatal and Pediatric Intensive Care Units.
This purchase supports Avanos’ Specialty Nutrition Systems segment and shows their dedication to providing safe and dependable care for newborn patients. Dave Pacitti, the CEO of Avanos, said this move fits perfectly with their plan to offer smarter and safer solutions in critical care. He is proud to bring Nexus’ TKO technology and products into Avanos’ lineup as part of their ongoing efforts to invest in innovation that helps doctors give consistent care and improve patient results.
Health Technology Insights: Madaket Health Appoints Megan Schmidt as Chief Executive Officer
The TKO connector uses a patented pressure-activated tri-seal silicone valve to reduce blood reflux, which is a common problem that can lead to catheter blockages, treatment delays, and infection risks during IV nutrition and medication delivery. Kerr Holbrook, Avanos’ Chief Commercial Officer, noted that the Nexus TKO is a great fit for their Specialty Nutrition Systems business and expects it to bring quick benefits in NICU and PICU settings.
He mentioned that the device is a dependable and easy-to-use solution that helps healthcare providers avoid disruptions and deliver therapy more consistently and smoothly. Avanos used its existing cash reserves to fund the acquisition and believes the deal will boost its revenue and earnings per share right away.
Health Technology Insights: University Hospitals Teams with Hippocratic AI for Patient Care
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
